Home

Betaferon results herald renewed funding warning

1998-02-19T00:00:00

Clinicians sounded a fresh warning this week over NHS funding constraints after claims that drugs to treat multiple sclerosis could benefit twice as many patients as first thought.

You need to be signed in to read more

HSJ

Subscribe for unlimited access

With a HSJ subscription you’ll unlock:

  • All of HSJ.co.uk and our HSJ mobile app
  • News and insight on all areas of public funded healthcare
  • Expert commentary, insight and analysis from industry leaders
  • 9 weekly ‘Expert Briefing’ insight emails covering a variety of specialist topics

Subscribe

to HSJ

Sign into your account here